CESCA THERAPEUTICS INC. (NASDAQ:KOOL) Files An 8-K Other Events

ME Staff 8-k
-
0

CESCA THERAPEUTICS INC. (NASDAQ:KOOL) Files An 8-K Other Events

Item 8.01.

Other Events.

Cesca Therapeutics Inc. (the Company) is filing this Current
Report on Form 8-K to update the description of its common stock
in its SEC filings.

Shares Authorized for Issuance

As of May 18, 2017, the Company is authorized, under its Sixth
Amended and Restated Certificate of Incorporation, as amended
(Certificate of Incorporation), to issue up to 350,000,000 shares
of common stock, $0.001 par value, and 2,000,000 shares of
preferred stock, $0.001 par value.

Common Stock

Each holder of the Companys common stock is entitled to one vote
for each share held on all matters submitted to a vote of the
stockholders, except matters that relate only to any outstanding
series of preferred stock that the Company may designate in the
future. No holder has any cumulative voting rights. Accordingly,
the holders of a majority of the shares of common stock entitled
to vote in any election of directors can elect all of the
directors standing for election, if they so choose.

Subject to preferences that may be applicable to any then
outstanding preferred stock, holders of common stock are entitled
to receive ratably those dividends, if any, as may be declared
from time to time by the board of directors out of legally
available funds. In the event of liquidation, dissolution or
winding up of the Company, holders of common stock will be
entitled to share ratably in the net assets legally available for
distribution to stockholders after the payment of all of debts
and other liabilities and the satisfaction of any liquidation
preference granted to the holders of any outstanding shares of
preferred stock.

Holders of common stock have no preemptive or conversion rights
or other subscription rights, and there are no redemption or
sinking fund provisions applicable to the common stock. All
outstanding shares of common stock are fully paid and
non-assessable. The rights, preferences, and privileges of the
holders of common stock are subject to, and may be adversely
affected by, the rights of the holders of shares of any series of
preferred stock that the Company may designate in the future.

Preferred Stock

The Company may, from time to time, issue preferred stock with
the rights, preferences and privileges established by the
Companys board of directors.

Effect of Certain Provisions of Certificate of Incorporation
and Bylaws

Some provisions of Delaware law and the Companys Certificate of
Incorporation and Restated Bylaws contain provisions that could
make the following transactions more difficult:

acquisition of the Company by means of a tender offer;

acquisition of the Company by means of a proxy contest or
otherwise; or

removal of the Companys incumbent officers and directors.

These provisions, summarized below, are expected to discourage
coercive takeover practices and inadequate takeover bids and to
promote stability in the Companys management. These provisions
are also designed to encourage persons seeking to acquire control
of the Company to first negotiate with the Companys board of
directors.

Undesignated Preferred Stock. The ability to
authorize undesignated preferred stock makes it possible
for the Companys board of directors to issue one or more
series of preferred stock with voting or other rights or
preferences that could impede the success of any attempt to
change control of the Company. These and other provisions
may have the effect of deterring hostile takeovers or
delaying changes in control or management of the Company.

Stockholder Meetings. The Companys Restated Bylaws
provide that a special meeting of stockholders may be
called only by the board of directors.

Requirements for Advance Notification of Stockholder
Nominations and Proposals. The Companys Restated Bylaws
establish advance notice procedures with respect to
stockholder proposals and the nomination of candidates for
election as directors, other than nominations made by or at
the direction of the Companys board of directors or a
committee of the board of directors.

Board of Directors Size and Vacancies.
Under the Companys Restated Bylaws, the board of directors
has the power to set the size of the board and fill any
vacancy on the board of directors, including a vacancy
resulting from an enlargement of the board. The ability to
increase or decrease the size of the board in conjunction
with the ability to fill a vacancy could make it more
difficult for a third party to acquire control of the
Company, or could discourage a third party from acquiring
control of the Company.

Exchange Listing

The Companys common stock is listed on the NASDAQ Capital Market
under the symbol KOOL.


About CESCA THERAPEUTICS INC. (NASDAQ:KOOL)

Cesca Therapeutics Inc. is clinical-stage biotechnology company. The Company develops and markets integrated cellular therapies and delivery systems. The Company is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. The Company focuses on the business of research, development and commercialization of autologous cell-based therapeutics for use in the regenerative medicine industry. The Company’s therapeutic development initiatives focuses on the fields of cardiovascular medicine and orthopedic regeneration. The Company offers a range of products, such as SurgWerks System, CellWerks System, AutoXpress System (AXP), MarrowXpress System (MXP), BioArchive System, and manual bag sets for use in the processing and cryogenic storage of cord blood.

CESCA THERAPEUTICS INC. (NASDAQ:KOOL) Recent Trading Information

CESCA THERAPEUTICS INC. (NASDAQ:KOOL) closed its last trading session up +0.05 at 3.14 with 4,855 shares trading hands.